ALT
USDAltimmune Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$3.920
고가
$4.160
저가
$3.775
거래량
2.59M
기업 기본 정보
시가총액
428.8M
산업
생명공학
국가
United States
거래 통계
평균 거래량
2.84M
거래소
NGM
통화
USD
52주 범위
관련 뉴스
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
Enrollment completed ahead of schedule, underscoring strong interest from patient community in a potential new therapeutic option On track to complete the 24-week treatment period and announce topline results in 2026
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera has become the obesity drug market's hottest ticket.
Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases,
관련 주식
WWD
Woodward Inc.
VC
Visteon Corporation
NJR
NewJersey Resources Corporation
DV
DoubleVerify Holdings Inc.
WTFCP
Wintrust Financial Corporation Depositary Shares Each Representing a 1/1000th Interest in a Share of 6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series E
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기